Skip to main content
Acta Pharmaceutica Sinica. B logoLink to Acta Pharmaceutica Sinica. B
. 2024 Feb 21;14(5):2358. doi: 10.1016/j.apsb.2024.02.013

Author correction to ‘Pharmacologically targeting molecular motor promotes mitochondrial fission for anti-cancer’ [Acta Pharm Sin B 11 (2021) 1853–1866]

Yi Qian a,, Meimei Zhao a,, Qinghua Han a, Jingkang Wang a, Lixi Liao a, Heng Yang a, Dan Liu b, Pengfei Tu a, Hong Liang a,, Kewu Zeng a,
PMCID: PMC11120276  PMID: 38799636

The authors regret that the representative images of tumor tissue staining for the intraperitoneal injection of J13 in the left panel of Fig. 5E and G (Page 1862) were incorrect due to an inadvertent mistake of copying and pasting in the process of assembling figures with Adobe Photoshop software. In our studies, at least three biological replicates were included in each treatment group and at least three images were taken for different fields of each sample. The corrected version of Fig. 5E and G have been provided below, and the change did not affect the results and conclusions of this study. The original data of these figures have been provided to the Editorial Office, and the corresponding authors or the Editorial Office can be contacted for original data access.

The authors apologize for any inconvenience caused to the journal and readers.

The revised images of Fig. 5E and G are:

Image 1

Footnotes

Peer review under the responsibility of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.

Contributor Information

Hong Liang, Email: lianghong@bjmu.edu.cn.

Kewu Zeng, Email: ZKW@bjmu.edu.cn.


Articles from Acta Pharmaceutica Sinica. B are provided here courtesy of Elsevier

RESOURCES